Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Titanium dioxide and bisoctrizole

EU orphan designation number: EU/3/05/262
Active ingredient: Titanium dioxide and bisoctrizole
Indication: Treatment of UV-A and visible light-induced photosensitivity disorders (chronic actinic dermatitis, cutaneous porphyrias, actinic prurigo and solar urticaria)
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, 31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2005 Orphan designation EMEA/OD/068/04 (2005)570 of 03/03/2005
30/05/2011 Change of name and/or address of sponsor EMEA/OD/068/04
12/07/2013 Removal of orphan designation from Community Register